Related stories
Scientific breakthrough harnesses mRNA technology to develop powerful malaria vaccine
A new mRNA vaccine targeting immune cells in the liver could be the key to tackling malaria, a disease that causes over half a million deaths each year according to the World Health Organization, yet has no effective long-lasting vaccine.
Trans-Tasman collaboration to develop a malaria vaccine
Prof Gavin Painter and his team at the Ferrier Research Institute are part of a trans-Tasman collaboration aiming to develop a simple and effective malaria vaccine that could be manufactured efficiently and administered easily in at-risk countries.